The Location of Pretreatment Hyperdense Middle Cerebral Artery Sign Predicts the Outcome of Intraarterial Thrombectomy for Acute Stroke

Journal of Neuroimaging

Volumn 25, Issue 2, 2015, Pages 263-268

  Man, Shumei ^a   Hussain, Muhammad Shazam ^a   Wisco, Dolora ^a   Katzan, Irene L ^a   Aoki, Junya ^a   Tateishi, Yohei ^a   Cheng Ching, Esteban ^a   Hui, Ferdinand K ^a   Masaryk, Thomas J ^a   Rasmussen, Peter A ^a   Uchino, Ken ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Hyperdense MCA sign; Mechanical thrombectomy; Outcome; Stroke

Indexed keywords

ADULT; ARTERY OCCLUSION; ARTICLE; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTRAARTERIAL THROMBECTOMY; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; MIDDLE CEREBRAL ARTERY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PREDICTION; RANKIN SCALE; SMOKING; AGED; BRAIN ANGIOGRAPHY; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; MIDDLE AGED; PREOPERATIVE CARE; PROCEDURES; PROGNOSIS; RADIOGRAPHY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STROKE;

AGED; CEREBRAL ANGIOGRAPHY; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MECHANICAL THROMBOLYSIS; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; PREOPERATIVE CARE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STROKE;

EID: 84924539037     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/jon.12115     Document Type: Article

References (26)

1. Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke rt-PA stroke study group. N Engl J Med 1995;333(24):1581-1587.
2. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359(13):1317-1329.
3. Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA 1999;282(21):2019-2026.
4. Endo S, Kuwayama N, Hirashima Y, et al. Results of urgent thrombolysis in patients with major stroke and atherothrombotic occlusion of the cervical internal carotid artery. AJNR Am J Neuroradiol 1998;19(6):1169-1175.
5. Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38(3):948-954.
6. Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380(9849):1241-1249.
7. Lansberg MG, Straka M, Kemp S, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 2012;11(10):860-867.
8. Gacs G, Fox AJ, Barnett HJ, Vinuela F. CT visualization of intracranial arterial thromboembolism. Stroke 1983;14(5):756-762.
9. Puig J, Pedraza S, Demchuk A, et al. Quantification of thrombus hounsfield units on noncontrast CT predicts stroke subtype and early recanalization after intravenous recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 2012;33(1):90-96.
10. Moftakhar P, English JD, Cooke DL, et al. Density of thrombus on admission CT predicts revascularization efficacy in large vessel occlusion acute ischemic stroke. Stroke 2013;44(1):243-245.
11. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42(2):377-381.
12. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. the PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282(21):2003-2011.
13. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368(10):893-903.
14. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS study group. Alberta stroke programme early CT score. Lancet 2000;355(9216):1670-1674.
15. Terasawa Y, Kimura K, Iguchi Y, et al. Could clinical diffusion-mismatch determined using DWI ASPECTS predict neurological improvement after thrombolysis before 3 h after acute stroke? J Neurol Neurosurg Psychiatr 2010;81(8):864-868.
16. Kent DM, Hill MD, Ruthazer R, et al. "Clinical-CT mismatch" and the response to systemic thrombolytic therapy in acute ischemic stroke. Stroke 2005;36(8):1695-1699.
17. Higashida RT, Furlan AJ, Roberts H, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34(8):e109-e137.
18. Paciaroni M, Agnelli G, Floridi P, et al. Hyperdense middle cerebral and/or internal carotid arteries in acute ischemic stroke: rate, predictive factors and influence on clinical outcome. Cerebrovasc Dis 2011;32(3):239-245.
19. Manelfe C, Larrue V, von Kummer R, et al. Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke 1999;30(4):769-772.
20. Tomsick T, Brott T, Barsan W, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol 1996;17(1):79-85.
21. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT investigators. Prolyse in acute cerebral thromboembolism. Stroke 1998;29(1):4-11.
22. Kharitonova T, Thoren M, Ahmed N, et al. Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance. J Neurol Neurosurg Psychiatr 2009;80(3):273-278.
23. Froehler MT, Tateshima S, Duckwiler G, et al. The hyperdense vessel sign on CT predicts successful recanalization with the merci device in acute ischemic stroke. J Neurointerv Surg 2013;5(4):289-293.
24. Riedel CH, Jensen U, Rohr A, et al. Assessment of thrombus in acute middle cerebral artery occlusion using thin-slice nonenhanced computed tomography reconstructions. Stroke 2010;41(8):1659-1664.
25. Assess the penumbra system in the treatment of acute stroke (THERAPY). http://clinicaltrials.gov/show/NCT01429350. Accessed January 29, 2014.
26. Yoo A, Heck D, Frei D, et al. Preliminary clot length analysis of anterior circulation large vessel occlusions. Stroke 2013;44:A193.